Yekaterina Chudnovsky

Executive

US·SEC (Form 4)

Elicio Therapeutics, Inc.Immix Biopharma, Inc.

Total declarations

Companies

▲ Purchases (1 ops.)

€6.4M

▼ Sales (0 ops.)

—

Latest filing published 29 May 2026 for Immix Biopharma, Inc..

Filing timeline

BuySale

Yekaterina Chudnovsky

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Elicio Therapeutics, Inc. 1 purchase · last 26 Dec 2023

Since each purchase

Elicio Therapeutics, Inc.
Filed 26 Dec 2023 · 1033 days ago · €6.4M
-34.7%
Entry US$7.76 · Close at T+365 US$5.07

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Yekaterina Chudnovsky: trading record in brief

Yekaterina Chudnovsky has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Elicio Therapeutics, Inc. and Immix Biopharma, Inc. We count 3 filings; the first trade dates from 22 December 2023 and the latest from 22 May 2026.

Purchases make up the whole of the open-market record (1 purchase, €6.4M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant.

The newest entry dates from 29 May 2026: a share grant, in Immix Biopharma, Inc. The last insider purchase was made public on 26 December 2023, 1,033 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.